Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03575585
What this trial is testing

BEing Safe in Treatment

Who this might be right for
Risk BehaviorSex, UnsafeSubstance Use+1 more
University of Washington 537
Not applicableLooking for participantsNCT07643948
What this trial is testing

Impacts of HIV Treatment Regimens on Archived Drug Resistance

Who this might be right for
HIV -1 InfectionAntiretroviral TherapyDrug Resistance, Microbial
Chinese University of Hong Kong 420
Testing effectiveness (Phase 2)Study completedNCT00001063
What this trial is testing

The Effectiveness of Three Drug Combinations in HIV-Infected Patients Who Have Taken Zidovudine for More Than 12 Weeks

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 200
Not applicableStudy completedNCT00002306
What this trial is testing

Fluconazole in the Treatment of Cryptococcal Meningitis in Patients Who Have Not Had Success With Amphotericin B

Who this might be right for
Meningitis, CryptococcalHIV Infections
Pfizer
Not applicableUnknownNCT06072443
What this trial is testing

AURORA Study-A Transformative Approach to Support PrEP Medication Persistence

Who this might be right for
HIV Infections
WV Health Right, Inc. 105
Not applicableWithdrawnNCT03869671
What this trial is testing

Pre-exposure Prophylaxis (PrEP) for People Who Inject Drugs (PWID)

Who this might be right for
Intravenous Drug Abuse
Boston University
Testing effectiveness (Phase 2)Study completedNCT01516593
What this trial is testing

Short Term Intensified Chemo-immunotherapy in HIV-positive Patients With Burkitt Lymphoma

Who this might be right for
HIVBurkitt's Lymphoma
Andres J. M. Ferreri 19
Not applicableStudy completedNCT00001998
What this trial is testing

Pharmacokinetics of Nystatin LF I.V. in Patients With Acquired Immune Deficiency Syndrome-Related Complex (ARC)

Who this might be right for
HIV Infections
Argus Pharmaceuticals
Not applicableStudy completedNCT01957748
What this trial is testing

CCTG 594: Engagement and Retention in Care for HIV+

Who this might be right for
Patient AdherenceHIV Positive
University of California, San Diego 117
Post-approval studies (Phase 4)Study completedNCT02522338
What this trial is testing

Measurement of Glomerular Filtration Rate (GFR) in HIV Patients: Single-center Study Comparing the Accuracy of Estimators of GFR Versus Iohexol Plasma Clearance

Who this might be right for
HIV
Centre Hospitalier Universitaire de Saint Etienne 300
Testing effectiveness (Phase 2)Study completedNCT00534352
What this trial is testing

Evaluate the Pharmacokinetic Profile (How the Body Absorbs, Distributes, Metabolizes and Eliminates a Drug) of TMC125 Plus Tenofovir/Emtricitabine Once Daily With or Without Darunavir/r Once Daily in Antiretroviral (ARV) Naive HIV-1 Patients (Patients Have Never Received ARV Treatment).

Who this might be right for
HIV-1 Infection
Tibotec, Inc 23
Testing effectiveness (Phase 2)Study completedNCT00006152
What this trial is testing

See If Taking One or Two Extra Drugs Can Lower HIV Levels in Patients Who Have Failed Their Anti-HIV Drug Treatment

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 42
Testing effectiveness (Phase 2)Study completedNCT00622206
What this trial is testing

Pharmacokinetics of Low Dose Ritonavir

Who this might be right for
HIV Infections
The HIV Netherlands Australia Thailand Research Collaboration 20
Early research (Phase 1)Study completedNCT00002344
What this trial is testing

Azithromycin in HIV-Infected Patients

Who this might be right for
Bacterial InfectionsHIV Infections
Pfizer 12
Not applicableStudy completedNCT01591252
What this trial is testing

Fracture and Bone Mineral Density in HIV+ Patients Recently Started on Antiretroviral Therapy (ART)

Who this might be right for
HIVOsteoporosis
University of Alabama at Birmingham 200
Not applicableApproved For MarketingNCT00097799
What this trial is testing

Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection

Who this might be right for
HIV Infections
Boehringer Ingelheim
Not applicableStudy completedNCT00002057
What this trial is testing

Nystatin Pastilles for the Prevention of Oral Candidiasis in Patients With AIDS or ARC

Who this might be right for
Candidiasis, OralHIV Infections
Bristol-Myers Squibb
Not applicableStudy completedNCT00859677
What this trial is testing

Immunologic Predisposition of HIV Patients to Develop Methicillin-Resistant Staphylococcus Aureus (MRSA) Colonization and Infection

Who this might be right for
HIV InfectionsStaphylococcal Infections
Henry M. Jackson Foundation for the Advancement of Military Medicine 52
Large-scale testing (Phase 3)Study completedNCT00001011
What this trial is testing

The Safety and Effectiveness of Zidovudine in the Treatment of Patients With Early AIDS Related Complex

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 538
Testing effectiveness (Phase 2)Study completedNCT00002221
What this trial is testing

Gene Therapy in HIV-Positive Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, Non-HodgkinHIV Infections
Ribozyome 5
Next Page